antibody,market,humanized,mylotarg,used,benefit,accelerated,approval,relapsed,acute,myeloid,leukemia,aml,voluntarily,withdrawn,study,failed,verify,survival,demonstrated,grafting,higher,granted,rate,murine,fatal,toxicity,chemotherapy,alone,complementarity